BioMarin Pharmaceutical
BMRN
#1924
Rank
A$15.17 B
Marketcap
A$78.42
Share price
-0.17%
Change (1 day)
-5.72%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Cash on Hand

Cash on Hand as of June 2026 : A$1.25 Billion

According to BioMarin Pharmaceutical's latest financial reports the company has A$1.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioMarin Pharmaceutical - Cash on Hand chart (from 1999 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$2.32 B27.38%
2024-12-31A$1.82 B16.05%
2023-12-31A$1.57 B-16.96%
2022-12-31A$1.89 B35.71%
2021-12-31A$1.39 B0.93%
2020-12-31A$1.38 B28.69%
2019-12-31A$1.07 B-30.05%
2018-12-31A$1.53 B-13.92%
2017-12-31A$1.78 B63.22%
2016-12-31A$1.09 B34.67%
2015-12-31A$0.81 B-29.56%
2014-12-31A$1.15 B31.28%
2013-12-31A$0.87 B104.16%
2012-12-31A$0.43 B126.48%
2011-12-31A$0.19 B-29.49%
2010-12-31A$0.26 B-19.38%
2009-12-31A$0.33 B-57.82%
2008-12-31A$0.79 B18.46%
2007-12-31A$0.66 B82.8%
2006-12-31A$0.36 B460.99%
2005-12-31A$65.31 M3.54%
2004-12-31A$63.08 M-77.28%
2003-12-31A$0.27 B111.43%
2002-12-31A$0.13 B-48.88%
2001-12-31A$0.25 B257.26%
2000-12-31A$71.9 M-24.99%
1999-12-31A$95.85 M524.36%
1998-12-31A$15.35 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Sanofi
SNY
A$10.37 B 729.22%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
A$0.41 B-66.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$39.47 M-96.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.22 B-82.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.42 B-66.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$1.08 B-13.52%๐Ÿ‡บ๐Ÿ‡ธ USA